GSK-207347

Study Sponsor: GSK

Study Title

Persistence of immune response to GSK Biologicals’ HPV vaccine in healthy Chinese female subjects from the HPV-058 study

Medicine or Vaccine (generic name)

Human Papillomavirus Types 16 and 18 Vaccine

Sponsor Identification Number

207347

Trial Registry Identification Number(#'s)

NCT03355820 2017-000255-50

Medical Condition

Cervical Intraepithelial Neoplasia

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is follow-up study to 112022. There is a Publication Steering Committee for this study.

Date Added to this Site

September 2020